MAM
KRRO icon

Meeder Asset Management’s Korro Bio KRRO Stock Holding History

Meeder Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-357
Closed -$13.6K – 977
2024
Q4 		$13.6K Buy
+357
New +$18.3K ﹤0.01% 632
2021
Q2 		– Sell
-57
Closed -$27K – 2588
2021
Q1 		$27K Buy
+57
New +$111K ﹤0.01% 1322

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meeder Asset Management's KRRO Position: Q1 2025 in Review

Meeder Asset Management sold out of Korro Bio (KRRO) in Q1 2025, closing a stake of 357 shares — an estimated $13.6K sold.

Meeder Asset Management first reported a position in KRRO in Q1 2021 and held it in 2 quarters. The position peaked at $27K in Q1 2021. 75 funds tracked by Wall St. Rank hold KRRO as of Q1 2025.

  • Meeder Asset Management reported no remaining Korro Bio position as of Q1 2025 after selling out during the quarter.
  • Meeder Asset Management sold 357 Korro Bio shares in Q1 2025, an estimated $13.6K.
  • Meeder Asset Management first reported a position in Korro Bio in Q1 2021 and held it in 2 quarters.
  • Meeder Asset Management's Korro Bio position peaked at $27K in Q1 2021.
  • 75 funds tracked by Wall St. Rank held Korro Bio as of Q1 2025.

Based on Meeder Asset Management's 13F filing for Q1 2025, filed 7 May 2025.